Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$72.36 - $113.1 $651 - $1,017
9 New
9 $1,000
Q1 2018

May 07, 2018

SELL
$39.4 - $47.39 $11,820 - $14,217
-300 Reduced 23.66%
968 $40,000
Q4 2017

Feb 08, 2018

BUY
$37.27 - $43.02 $12,671 - $14,626
340 Added 36.64%
1,268 $0
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $31,320 - $38,669
928
928 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.